Rimonabant is certified for the treatment of predominance.

According to whether humans are actively (work, sport) or relaxed and passive (meal, sleep), the bodily functions are regulated by different parts unconscious nervous systems.

A part of this system is the Endocannabinoid in such a way specified system. It steers among other things the energy balance, the sugar and the fat metabolism as well as the body weight. Besides it plays a role with the desire on very sweet or very fat food.

The Endocannabinoid system is activated, if a hunger feeling begins. If this system is falsely active continuously, feels the concerning increases hunger and many more than necessarily eats.

Rimonabant is a CB1-Rezeptor blocker. It normalizes the overactivity of the Endocannabinoid of system.

Rimonabant should be used only with strong predominance (BMI ? 30), if calorie-poor food, change of the eating habits and the movement did not have the desired effect and additional factors of risk for heart cycle illnesses to exist as for instance diabetes type of 2 or high blood fat values.